Caspase 7: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 32: | Line 32: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 06:19, 17 March 2025
Caspase 7, also known by its systematic name cysteine-aspartic acid protease 7, is a protein that in humans is encoded by the CASP7 gene. It is a member of the caspase family, enzymes that play a central role in the execution-phase of cellular apoptosis. Caspase 7 is an effector caspase, primarily involved in the cleavage of cellular proteins leading to cell death. This enzyme is closely related to Caspase 3, sharing a high degree of sequence and functional similarity.
Function[edit]
Caspase 7 is synthesized as an inactive proenzyme that is processed in cells undergoing apoptosis by self-proteolysis and cleavage by other caspases, such as caspase-8, caspase-9, and caspase-10. Activation of caspase 7 results in the cleavage of several key cellular proteins, including poly (ADP-ribose) polymerase (PARP), an important protein in DNA repair and cellular maintenance. The activity of caspase 7 is regulated by inhibitor of apoptosis proteins (IAPs) and by the Bcl-2 protein family, which governs the mitochondrial release of cytochrome c, a critical step in apoptosis.
Clinical Significance[edit]
Alterations in caspase 7 expression and activity have been linked to a variety of diseases, including cancer, neurodegenerative diseases, and inflammatory diseases. In cancer, caspase 7 can function as a tumor suppressor, as its apoptotic activity can limit the survival of malignant cells. Conversely, excessive caspase 7 activity has been associated with the progression of neurodegenerative diseases such as Alzheimer's disease, where it contributes to neuronal cell death.
Genetic Structure[edit]
The CASP7 gene is located on chromosome 10q25.3 and consists of 9 exons. Mutations in this gene have been studied for their potential role in disease pathogenesis, although such mutations are relatively rare.
Therapeutic Potential[edit]
Given its central role in apoptosis, caspase 7 has been explored as a target for therapeutic intervention in various diseases. Inhibitors of caspase 7 have been considered for the treatment of conditions where excessive apoptosis contributes to disease pathology, such as in certain neurodegenerative diseases. Conversely, activation of caspase 7 may have therapeutic benefits in cancer, promoting the apoptosis of cancer cells.
See Also[edit]
References[edit]
<references />
External Links[edit]
- CASP7 gene on NCBI
- Caspase 7 on UniProt
